News Focus
News Focus
icon url

sox040713

11/16/16 4:14 PM

#164069 RE: iclight #164062

Of course I know there are other ways to stop tumor growth without p53 reactivation. But we are talking about K correct? Are you saying that the increase in p21 expression which led to stable disease in some ovarian patients were pure coincidence and had nothing to do with K?
icon url

BonelessCat

11/16/16 5:20 PM

#164074 RE: iclight #164062

Here is how the lesion disappearance was reported:
" According to information supplied by the hospital, the patient, who successfully completed three Kevetrin 3-dose cycles before discontinuing the trial, experienced increased energy, while scans showed a reduction in the amount of peritoneal fluid (ascites) during treatment with Kevetrin. Subsequent to the second and third Kevetrin cycles, scans showed the spleen lesion to be essentially undetectable and the patient’s disease to be clinically stable." - See more at: http://cellceutix.com/cellceutix-reports-spleen-lesion-disappears-in-patient-with-metastatic-stage-4-ovarian-cancer-in-clinical-trial-of-anti-cancer-drug-kevetrin/#sthash.rI8bYvEQ.dpuf

So Dana Farber reported this, though I guess we have to take Leo's word that Dana Farber did report it. Never mind that if the account is factually incorrect, all hell would have broken loose from the Dana Farber side.